<DOC>
	<DOCNO>NCT01755104</DOCNO>
	<brief_summary>The purpose study evaluate impact intake dietary supplement STABLOR™ change abdominal visceral fat mass patient metabolic syndrome .</brief_summary>
	<brief_title>Effect Stablor Visceral Fat Loss Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>With Body Mass Index ( BMI ) equal 25 kg/m² less 40 kg/m² , With metabolic syndrome characterize waist circumference 94 cm male ( 90 cm SouthAsians , Chinese Japanese ) 80 cm female , least 2 follow criterion : Arterial Blood pressure &gt; = 130 mmHg ( systolic ) and/or equal 85 mmHg ( diastolic ) stabilize treatment least 6 month , Fasting glycemia &gt; = 1 g/L 5.6 mmol/L stabilize treatment least 6 month nondiabetic &lt; 1.26 g/L , Triglycerides &gt; = 1.5 g/L 1.71 mmol/L stabilize treatment least 6 month , HDL Cholesterol &lt; 0.40 g/L 1.03 mmol/L ( male ) &lt; 0,5 g/l 1.29 mmol/L ( female ) stabilize treatment least 6 month . Pregnant ( positive pregnancy test selection visit breastfeed woman , Woman childbearing potential without efficient contraception method , The information intend contain consideration relevant patient 's potential participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>